CNW/ - Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by public drug programs in Ontario, ...
Libtayo® (cemiplimab for injection) Now Reimbursed in Québec for Advanced Non-Small Cell Lung Cancer
TORONTO, Oct. 30, 2025 /CNW/ - Regeneron Canada Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by Régie de l'assurance ...
New corporate brand reflects strategic transformation to a global biotech platform accelerating access to innovative ...
Toasted skin syndrome causes a net-like rash to appear where the skin has been exposed to a heat source. It may resolve on ...
Q2 2026 Earnings Call Transcript October 27, 2025 Operator: Greetings, and welcome to the SIFI Technologies Financial Results ...
Lantern today announced it will present two commercially deployed AI research platforms at the inaugural AI for Biology and Medicine (AI4BM) symposium at the University of North Texas. The symposium, ...
The news on vaccines was not so good, as declining sales of shingles shot Shingrix in the US and China pegged back growth to ...
Successful start to the conference “AI in Photonics – Adding Value in Laser Manufacturing Technology & Optical Design on October 1, 2025, in Berlin.
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor, ...
Q3 2025 Earnings Call October 30, 2025 4:30 PM EDTCompany ParticipantsJacquie Ross - Senior Vice President of Treasury ...
If you look at the moving pieces of working capital, receivables very much in line. Normally in Q3, you see a typical seasonal impact of a few days more DSO. Usually, year-end is always the best. So ...
Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data, today announced the launch of six new hematology Panoramic datasets, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results